Pharma sector to be in focus this week in F&O segment with strong long build up witnessed in stocks like Zydus Life, Lupin, Lauruslabs, Divislab, and Dr. Reddy s.
The Nifty, which gained almost a percent in the past week, is expected to trade higher, say analyst in view of the macroeconomic factors and technical analysis. The index will remain bullish as long as it remains above 18,950, they say
Despite the underperformance of stocks in the derivatives market last week, some sectors, such as banking have remained stable when compared to the volatility 14 days ago